AGENUS INC Sales Revenue, Services, Net (Deprecated 2018-01-31)
AGENUS INC (AGEN) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $147.46 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2018-03-16
- AGENUS INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $0.00.
- AGENUS INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $0.00.
- AGENUS INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $0.00.
- AGENUS INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $147.46K.
- AGENUS INC sales revenue, services, net (deprecated 2018-01-31) for fiscal 2016 was $147.46K.
- AGENUS INC sales revenue, services, net (deprecated 2018-01-31) for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- AGENUS INC sales revenue, services, net (deprecated 2018-01-31) for fiscal 2013 was $1.42M, a 4.83% decline from fiscal 2012.
- AGENUS INC sales revenue, services, net (deprecated 2018-01-31) for fiscal 2012 was $1.49M.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $147.46K 10-K · filed 2018-03-16 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $147.46K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $147.46K 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $147.46K 10-Q · filed 2017-05-04 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 |
| 2014-09-30 | $0.00 10-Q · filed 2014-10-31 | $0.00 derived: sum of 2 quarters · filed 2014-10-31 | $0.00 10-Q · filed 2014-10-31 | $14.91K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-01 | $0.00 10-Q · filed 2014-08-01 | $14.91K derived: sum of 3 quarters · filed 2016-03-15 | $372.10K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 | $14.91K derived: sum of 2 quarters · filed 2016-03-15 | $372.10K derived: sum of 3 quarters · filed 2016-03-15 | $692.64K derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $14.91K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $372.10K derived: sum of 2 quarters · filed 2016-03-15 | $692.64K derived: sum of 3 quarters · filed 2016-03-15 | $1.42M 10-K · filed 2016-03-15 |
| 2013-09-30 | $357.20K 10-Q · filed 2014-10-31 | $677.73K derived: sum of 2 quarters · filed 2014-10-31 | $1.40M 10-Q · filed 2014-10-31 | $2.11M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $320.54K 10-Q · filed 2014-08-01 | $1.05M 10-Q · filed 2014-08-01 | $1.75M derived: sum of 3 quarters · filed 2015-03-16 | $2.24M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $725.23K 10-Q · filed 2014-05-09 | $1.43M derived: sum of 2 quarters · filed 2015-03-16 | $1.92M derived: sum of 3 quarters · filed 2015-03-16 | $2.16M derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $708.23K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $1.20M derived: sum of 2 quarters · filed 2015-03-16 | $1.43M derived: sum of 3 quarters · filed 2015-03-16 | $1.49M 10-K · filed 2015-03-16 |
| 2012-09-30 | $486.83K 10-Q · filed 2013-11-08 | $722.87K derived: sum of 2 quarters · filed 2013-11-08 | $781.59K 10-Q · filed 2013-11-08 | |
| 2012-06-30 | $236.03K 10-Q · filed 2013-08-09 | $294.76K 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $58.72K 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-07 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |